Activating p53 and Inhibiting Superenhancers to Cure Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activating p53 and Inhibiting Superenhancers to Cure Leukemia

Published:2018-12 Issue:12 Volume:39 Page:1002-1004
ISSN:0165-6147
Container-title:Trends in Pharmacological Sciences
language:en
Short-container-title:Trends in Pharmacological Sciences

Author:

Ball Brian,Abdel-Wahab Omar

Funder

NIH/NHLBI

Department of Defense Bone Marrow Failure Research Program

Henry & Marilyn Taub Foundation

Edward P. Evans Foundation

Leukemia and Lymphoma Society

Pershing Square Sohn Cancer Research Alliance

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference9 articles.

1. Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis;Schittek;Mol. Cancer,2014

2. CKIalpha ablation highlights a critical role for p53 in invasiveness control;Elyada;Nature,2011

3. Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding;Wu;Mol. Cell. Biol.,2012

4. Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS;Kronke;Nature,2015

5. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS;Schneider;Cancer Cell,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wogonin protects against bleomycin-induced mouse pulmonary fibrosis via the inhibition of CDK9/p53-mediated cell senescence;Frontiers in Pharmacology;2024-07-08

2. PROTACs: great opportunities for academia and industry (an update from 2020 to 2021);Signal Transduction and Targeted Therapy;2022-06-09

3. Super-Enhancers in the Regulation of Gene Transcription: General Aspects and Antitumor Targets;Acta Naturae;2021-03-15

4. Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion;European Journal of Medicinal Chemistry;2021-02

5. Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy;Expert Opinion on Investigational Drugs;2021-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3